Key facts
- Latitude Food Allergy Care’s last known valuation is $37.9M (Aug 2022).
- It has raised $24.6M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Slow Ventures, AllerFund Ventures, Altos Health.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Latitude Food Allergy Care
- ·The full record, as it builds
Funding rounds
No funding rounds for Latitude Food Allergy Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Latitude Food Allergy Care
Operator of a food allergy care platform intended to treat children with a personalized treatment plan. The company offers expert medical assessment and testing, personalized oral immunotherapy and long-term allergy monitoring, early food introduction, and ongoing clinical support to effectively reduce the risk of anaphylactic reactions, enabling families and individuals with food allergies to better understand triggers, reduce the risk of reactions, and improve quality of life.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2017
- Employees
- 55
- Website
- latitudefoodallergycare.com/
- Ownership
- Privately Held (backing)
Latitude Food Allergy Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Latitude Food Allergy Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Latitude Food Allergy Care in its N-PORT filings yet. We sweep new filings monthly.